查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495439

冠状动脉疾病市场：按类型、最终用户划分 - 2024-2030 年全球预测

Coronary Artery Disease Market by Type (Diagnostics, Treatment), End-User (Ambulatory Surgery Centers, Diagnostic Centers, Hospitals & Clinics) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年冠心病市场规模为118.8亿美元，预计2024年将达125.3亿美元，2030年将达174.9亿美元，复合年增长率为5.68%。

冠状动脉疾病 (CAD) 是一种以冠状动脉阻塞或狭窄为特征的疾病，冠状动脉是向心臟供应氧气和营养的主要血管。这种疾病主要是由动脉壁上的斑块堆积引起的，斑块由脂肪、胆固醇和其他物质组成。这种积聚会限制流向心臟的血液，导致胸痛等症状，严重时还会导致心臟病发作。导致 CAD 传播的主要因素包括人口老化以及肥胖、糖尿病、不良饮食、缺乏运动和吸烟等生活方式相关风​​险的增加。然而，先进治疗设备的高成本以及与 CAD 设备相关的产品召回问题正在阻碍市场成长。儘管存在这些挑战，个人化医疗和新型治疗方法的持续努力预计将提供量身定制的治疗方案并减轻这种疾病的整体负担。

主要市场统计
基准年[2023] 118.8亿美元
预测年份 [2024] 125.3亿美元
预测年份 [2030] 174.9亿美元
复合年增长率（%） 5.68%

区域洞察

美洲，尤其是美国，由于先进的医疗基础设施和 CAD 的高盛行率而呈现强劲的市场成长，增加了对先进治疗的需求。此外，对医疗保健的大量投资和对冠状动脉疾病的高度认识正在推动该地区的市场。欧洲展示了强大的医疗保健系统和强有力的法律规范，支持 CAD 的有效管理。在中东和非洲，医疗发展和 CAD 意识的提高正在推动市场成长。在中国和印度等人口大国医疗保健支出增加以及对心血管疾病意识提高的推动下，亚太地区 CAD 市场正在快速成长。此外，医疗保健基础设施的改善和中阶的不断壮大也促进了对心臟病治疗的更多关注和市场扩张。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在冠状动脉疾病市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对冠状动脉疾病市场中供应商的现状进行深入而详细的评估。对供应商贡献的彻底比较和分析可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在冠状动脉疾病市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化导致冠心病发病率增加
      • 由于医疗基础设施投资增加而扩大医疗基础设施
    • 抑制因素
      • 深度处理设备高成本，先进技术商业化受到限制
    • 机会
      • CAD 管理产品的进步与改进
      • 持续扩大微创手术和手术中心
    • 任务
      • 因安全问题而涉及产品召回的问题
  • 市场区隔分析
    • 类型：对手术的需求不断增加，以有效管理 CAD 并提高生活质量
    • 最终使用者：高度偏好提供全面 CAD 照护的医院和诊所
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 冠状动脉疾病市场：依类型

  • 诊断
  • 治疗

第七章 冠状动脉疾病市场：依最终使用者分类

  • 门诊手术中心
  • 诊断中心
  • 医院/诊所

第八章美洲冠状动脉疾病市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区冠心病市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的冠心病市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Abbott 推出改良的 Xience Sierra 支架系统以改善心臟治疗
    • 创新Start-Ups利用人工智慧技术彻底改变冠状动脉疾病检测
  • 战略分析和建议

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5D693B46C822

[194 Pages Report] The Coronary Artery Disease Market size was estimated at USD 11.88 billion in 2023 and expected to reach USD 12.53 billion in 2024, at a CAGR 5.68% to reach USD 17.49 billion by 2030.

Coronary artery disease (CAD) is a medical condition characterized by the blockage or narrowing of coronary arteries, which are major blood vessels supplying oxygen and nutrients to the heart. This disease is primarily caused by the buildup of plaque, a combination of fat, cholesterol, and other substances in the artery walls. This buildup restricts the blood flow to the heart, leading to symptoms, including chest pain and, in severe cases, heart attacks. The major factors that contribute to the expansion of CAD include an aging population and increased prevalence of lifestyle-related risks such as obesity, diabetes, poor diet, physical inactivity, and smoking. However, the high costs of advanced therapeutic devices and product recall issues associated with CAD devices hinder market growth. Despite these issues, growing initiatives in personalized medicine and new therapeutic approaches are expected to provide tailored treatment options, reducing the overall burden of the disease.

KEY MARKET STATISTICS
Base Year [2023] USD 11.88 billion
Estimated Year [2024] USD 12.53 billion
Forecast Year [2030] USD 17.49 billion
CAGR (%) 5.68%

Regional Insights

The Americas, particularly the United States, shows strong market growth owing to advanced healthcare infrastructure and a high prevalence of CAD, raising the need for advanced treatments. Additionally, significant investment in healthcare and high awareness about coronary artery disease drives the market in the region. Europe exhibits a robust healthcare system and strong regulatory frameworks that aid in the effective management of CAD. In the Middle East and Africa, the market in this region is growing, driven by increasing healthcare development and rising awareness of CAD. Asia-Pacific is experiencing rapid growth in the CAD market, propelled by increasing healthcare expenditure and growing awareness of cardiovascular diseases in populous countries, including China and India. Further, improvements in healthcare infrastructure and the rising middle class are contributing to a stronger focus on heart disease treatments and an expanding market.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Coronary Artery Disease Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising incidences of coronary artery disease due to aging populations
      • Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
    • Market Restraints
      • High cost of advanced therapeutic devices and limited commercialization of advanced technologies
    • Market Opportunities
      • Advancements and improvements in CAD management products
      • Continuous expansion of minimally invasive procedures and surgery centers
    • Market Challenges
      • Problems associated with product recalls due to safety concerns
  • Market Segmentation Analysis
    • Type: Growing need for surgeries to manage CAD effectively and improve the quality of life
    • End-User: Higher preferences for hospitals and clinics that offer integrated CAD care
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Coronary Artery Disease Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Coronary Artery Disease Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Abbott Introduces Enhanced Xience Sierra Stent System for Improved Cardiac Care

Abbott Laboratories unveiled the Xience Sierra coronary stent system, which is designed to assist patients suffering from coronary artery disease. The newly launched stent system represents an advancement in the treatment of heart ailments by offering greater flexibility and a wider range of sizes compared to previous models. This innovation aims to cater to complex and challenging anatomies, thereby potentially increasing the success rates of angioplasty procedures. [Published On: 2024-05-03]

Innovative Startup Revolutionizes Coronary Artery Disease Detection with AI Technology

Genexia has developed a cutting-edge artificial intelligence (AI) system aimed at improving the diagnosis of coronary artery disease (CAD). This AI tool integrates seamlessly with existing medical imaging technologies to analyze cardiovascular images with heightened accuracy and speed, thereby facilitating earlier and more precise diagnoses of CAD. The technology promises to enhance patient outcomes by enabling timely medical intervention and stands to significantly reduce the workload of cardiologists by automating complex diagnostic processes. Th [Published On: 2024-02-09]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Coronary Artery Disease Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences, FUJIFILM Holdings Corporation, GE HealthCare Technologies, Inc., Genesee Biomedical Inc., Getinge AB, Hitachi, Ltd., Koninklijke Philips N.V., Medtronic PLC, Merck KGaA, MicroPort Scientific Corporation, Siemens Healthineer AG, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Diagnostics
      • Cardiac Catheterization & Angiogram
      • Echocardiogram
      • Electrocardiogram
      • Exercise Stress Test
      • Heart CT Scan
      • Nuclear Stress Test
    • Treatment
      • Medications
        • Angiotensin-converting Enzyme Inhibitors & Angiotensin II Receptor Blockers Nitroglycerin
        • Aspirin
        • Beta-blockers
        • Calcium Channel Blockers
        • Cholesterol Drugs
        • Ranolazine
      • Surgeries
        • Coronary Angioplasty & Stent Placement
        • Coronary Artery Bypass Graft Surgery
  • End-User
    • Ambulatory Surgery Centers
    • Diagnostic Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of coronary artery disease due to aging populations
      • 5.1.1.2. Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced therapeutic devices and limited commercialization of advanced technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CAD management products
      • 5.1.3.2. Continuous expansion of minimally invasive procedures and surgery centers
    • 5.1.4. Challenges
      • 5.1.4.1. Problems associated with product recalls due to safety concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing need for surgeries to manage CAD effectively and improve the quality of life
    • 5.2.2. End-User: Higher preferences for hospitals and clinics that offer integrated CAD care
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Coronary Artery Disease Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostics
  • 6.3. Treatment

7. Coronary Artery Disease Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Diagnostic Centers
  • 7.4. Hospitals & Clinics

8. Americas Coronary Artery Disease Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Coronary Artery Disease Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Coronary Artery Disease Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Abbott Introduces Enhanced Xience Sierra Stent System for Improved Cardiac Care
    • 11.3.2. Innovative Startup Revolutionizes Coronary Artery Disease Detection with AI Technology
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CORONARY ARTERY DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. CORONARY ARTERY DISEASE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CORONARY ARTERY DISEASE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIAC CATHETERIZATION & ANGIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIAC CATHETERIZATION & ANGIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EXERCISE STRESS TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EXERCISE STRESS TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HEART CT SCAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HEART CT SCAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY NUCLEAR STRESS TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY NUCLEAR STRESS TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN II RECEPTOR BLOCKERS NITROGLYCERIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN II RECEPTOR BLOCKERS NITROGLYCERIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ASPIRIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CHOLESTEROL DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CHOLESTEROL DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY RANOLAZINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY RANOLAZINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ANGIOPLASTY & STENT PLACEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ANGIOPLASTY & STENT PLACEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND CORONARY ARTERY D